Infographic: Underprescribing widespread among patients at risk of stroke

Improved prescribing of lipid-lowering, anticoagulant and antihypertensive drugs could prevent 12,000 strokes a year, a large study suggests.

Analysis of primary care records from a database covering approximately 6% of the UK population has shown that one-third of all strokes or TIAs occurred in patients in whom prevention drugs were clinically indicated but not prescribed. 

Extrapolating their findings based on estimates of the UK population and stroke incidence, the researchers estimated that 41,405 first stroke patients are eligible for but not prescribed lipid-lowering, anticoagulant, or antihypertensive drugs annually.

Considering the effectiveness of these treatments, the number of strokes that could potentially be prevented each year in the UK by optimal prescribing is estimated to be 11,823.

Of the three prevention drugs, lipid-lowering drugs were the most commonly clinically indicated; over half of the people who had a stroke or TIA were eligible for these drugs. 

In some cases the prevention drugs had been prescribed but then stopped. Overall, 54% of patients not prescribed antihypertensive drugs when clinically indicated had previously been prescribed these drugs, compared with 14% for anticoagulant drugs and 30% for lipid-lowering drugs.

Underprescribing of anticoagulants decreased from 58% to 45% between 2009 and 2013, but there was no reduction in the underprescribing of lipid-lowering or antihypertensive drugs during this period. 

Barriers to prescribing

The authors acknowledge there may be legitimate reasons for not prescribing stroke prevention drugs to people with clinical indications, such as bleeding risk with anticoagulant drugs or knowledge of a patient’s adherence to medication. They also note that their definition of underprescribing did not address patients’ adherence to medication or medication targets, such as blood pressure levels.

However, evidence suggests GPs may overestimate side-effects and underestimate the benefits of stroke prevention drugs for elderly patients. Lack of familiarity or agreement with treatment guidelines also reduces adherence to recommended prescribing practice. 

Given that stroke is the second leading cause of death and third leading cause of disability-adjusted life-years lost worldwide, the researchers' findings highlight that improving prescription of lipid-lowering, anticoagulant, and antihypertensive drugs is important to reduce the incidence and burden of stroke and TIA.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases